Amarin | 운영 비용



Operating Expenses 변화 날짜
AbbVie USD 16.59B 5.96B 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amarin USD 67.47M 549K 2024-09
AstraZeneca USD 12.86B 2.06B 2024-12
DBV Technologies USD 31.4M 3.6M 2024-09
GlaxoSmithKline GBP 7.42B 402M 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 11.28B 1.73B 2024-12



Amarin 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2025.